A dire wolf de-extinction debate, CRISPR-GPT for gene editing, and more topped the list of our most popular stories in ...
It was the best of times, it was the worst of times for research in 2025. | It was the best of times and it was the worst of times for research in 2025. Medical breakthroughs and stunning discoveries ...
Explore 2025's groundbreaking scientific discoveries: the MoM-z14 galaxy, personalised CRISPR therapy, regenerative medicine, ...
As Future Perfect has in past years, we’re spending this holiday season rounding up our most-read stories of 2025 — a quick ...
Transposon sequencing analyses reveal that among genomically diverse clinical Mycobacterium intracellulare strains and the type strain, 131 genes were comprehensively identified as universal essential ...
Approaches incorporating rapid or digital PCR, CRISPR, syndromic testing, and multimodal systems reached new milestones this year.
In 2023, the AI market in pharmaceuticals and biotech was valued at $1.8 billion, and it’s expected to grow to $13.1 billion ...
Zacks Small Cap Research on MSN

DYAI: Layers of commercialization agreements

The new arrangements were all announced in December and include a development and commercialization agreement signed with BRIG BIO, a commercial partnership with Opes Diagnostics and an expansion of ...
Chronic alcohol consumption disrupts gut equilibrium, leading to "leaky gut" and systemic inflammation. Dr. Rakesh Gupta ...
Festive favorites of the holiday season, reindeer possess remarkable genomic adaptations that allow them to thrive in the ...